so sites must reevaluate their quality and safety credentials and maintain a state of good manufacturing practice (GMP) readiness. Throughout the pandemic, the lack of FDA inspections has created ...
It's one of many steps for the company as it builds the infrastructure for what "will change medicine everywhere in the world ...
Indian medical device manufacturers are enhancing GMP compliance and embracing proactive strategies to meet rising USFDA ...
The FDA stated that the Kirkland recall was ... most likely occurred due to deviations from CGMP (Current Good Manufacturing Practice). "[That means] the product failed to meet required quality ...
On January 6, the U.S. Food and Drug Administration (FDA) issued long-awaited draft guidance regarding Establishing Sanitation Programs ...
Telangana: Gland Pharma has received Establishment Inspection Report (EIR) from the United States Food and Drug ...
Gland Pharma receives EIR from US FDA for Dundigal facility, indicating closure of inspection with no major concerns.
The FDA rejected J&J's subcutaneous amivantamab due to manufacturing issues, not safety or efficacy concerns, affecting only the new formulation. The subcutaneous version aimed to provide a more ...
including but not limited to 21 CFR Part 820 and Good Manufacturing Practices ("GMP"). This FDA registration and product listing is in addition to MVE's existing ISO 13485 certification.